Showing 361-370 of 598 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21093/Re-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21764/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21819/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Hair Challenges and Treatments Around the World
https://practicaldermatology.com/issues/september-2026/hair-challenges-treatments-around-the-world/70060/Experts from different continents sharewhat is trending in their regions.